Aticaprant from MedChemExpress

Product Specs
ItemAticaprant
CompanyMedChemExpress
Price $110.00Supplier Page View Company Product Page
Catalog NumberHY-101718
Quantity10 mM * 1 mL
ApplicationsBioactivity, Structure and function analysis, ELISA, SDS-PAGE, Western blotting
Purity99.59%
TypeChemical
Molecular Weight418.5
FormulaC₂₆H₂₇FN₂O₂
Research AreaNeurological Disease

Add to Compare List

MedChemExpress

1 Deer Park Drive, Suite F

MONMOUTH JUNCTION, NJ 08852

United States

Phone: US Tel: 609-228-6898
US Fax: 609-228-5909
EU Tel: +4686500910

Email: sales@medchemexpress.com
eu.sales@MedChemExpress.com

Company Profile

Website: medchemexpress.com

(1) Mapping Kappa Opioid Receptor Binding in Titi Monkeys with [ 11 C]GR103545 PETMolecular ImagingNovember 1, 2025Alita Jesal D Almeida, Brad A. Hobson, Logan E. Savidge, Claudia Manca, John P. Paulus, Karen L. Bales, Abhijit J. Chaudharipre-treatment with KOR antagonist CERC-501 (Supplier: MedChemExpress, Monmouth Junction, NJ, Cat. No.: HY-101718), administered (0.3 mg/kg, i.v.) to the same n = 6 titi monkeys, 10-min prior to radiotracer administration.

(2) Kappa opioid receptors diminish spontaneous dopamine signals in awake mice through multiple mechanismsNeuropharmacologyAugust 1, 2025Conner W. Wallace, Katherine M. Holleran, Clare Y. Slinkard, Samuel W. Centanni, Christopher C. Lapish, Sara R. JonesNIH and dissolved in saline at 1 mg/mL. Aticaprant (MedChemExpress, Monmouth Junction, NJ; Product: HY-101718, CAS: 1174130-61-0) was dissolved in 5% DMSO / 5% Cremophor / 90% saline at 2 mg/mL. 2.6. Theory and

(3) Kappa Opioid Receptors Negatively Regulate Real Time Spontaneous Dopamine Signals by Reducing Release and Increasing UptakebioRxivFebruary 11, 2024Conner W Wallace, Katherine M Holleran, Clare Y Slinkard, Samuel W Centanni, Sara R Jonesbetween several days of washout. 2.5. Drugs Aticaprant (MedChemExpress, Monmouth Junction, NJ; Product: HY-101718, CAS: 1174130-61-0) was dissolved in 5% DMSO / 5% Cremophor / 90% saline at 2 mg/mL. U50,488H (RTI Log

(4) Effects of orally-bioavailable short-acting kappa opioid receptor-selective antagonist LY2456302 on nicotine withdrawal in miceNeuropharmacologyOctober 1, 2015Jackson KJ, Jackson A, Carroll FI, Damaj MI.

(5) LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disordersNeuropharmacologyFebruary 1, 2014Rorick-Kehn LM, Witkin JM, Statnick MA, Eberle EL, McKinzie JH, Kahl SD, Forster BM, Wong CJ, Li X, Crile RS, et al.

Be the First to Write a Review!

Aticaprant from MedChemExpress

Description

MedChemExpress

Citations (5)

Reviews

Aticaprant from MedChemExpress

About Biocompare

Advertise with Us

Specialized Search Tools

Site Map